SOTOXEN is a medicine widely used to treat adults with non-small cell lung cancer (NSCLC) that has enhanced to other parts of the body or is resistant to surgery. Its tumor has an aberrant KRAS G12C gene, and those who have had at least one prior treatment for their cancer.